DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's laboratories Limited
02 1Virupaksha Organics Limited
03 1AURORE PHARMACEUTICALS PRIVATE LIMITED
04 1Aurobindo Pharma Limited
05 1Cipla Ltd.
06 1Curia Italy S.r.l.
07 1Derivados Quimicos
08 2Hetero Drugs Limited
09 2Jubilant Pharmova Limited
10 1MYLAN LABORATORIES LIMITED
11 1Natco Pharma Limited
12 1Raks Pharma Pvt. Limited
13 1Tianish Laboratories Private Limited
14 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
01 4CITALOPRAM HYDROBROMIDE
02 9Citalopram Hydrobromide
03 1citalopram
04 2citalopram hydrobromide
01 1China
02 12India
03 1Spain
04 2U.S.A
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-902
Start Marketing Date : 2009-03-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51686-0007
Start Marketing Date : 2024-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7738
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55486-1572
Start Marketing Date : 2012-06-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59349-0010
Start Marketing Date : 2018-11-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1101
Start Marketing Date : 2001-08-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63850-3616
Start Marketing Date : 2016-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 47621-022
Start Marketing Date : 2012-08-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-721
Start Marketing Date : 2015-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64220-105
Start Marketing Date : 2011-02-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Citalopram Hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Citalopram Hydrobromide, including repackagers and relabelers. The FDA regulates Citalopram Hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Citalopram Hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Citalopram Hydrobromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Citalopram Hydrobromide supplier is an individual or a company that provides Citalopram Hydrobromide active pharmaceutical ingredient (API) or Citalopram Hydrobromide finished formulations upon request. The Citalopram Hydrobromide suppliers may include Citalopram Hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Citalopram Hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Citalopram Hydrobromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Citalopram Hydrobromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Citalopram Hydrobromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Citalopram Hydrobromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Citalopram Hydrobromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Citalopram Hydrobromide suppliers with NDC on PharmaCompass.
We have 14 companies offering Citalopram Hydrobromide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?